GoodRx Holdings (GDRX) Short term Debt (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of Short term Debt data on file, last reported at $5.0 million in Q1 2026.

• For the quarter ending Q1 2026, Short term Debt changed 0.0% year-over-year to $5.0 million; the trailing twelve-month figure through Mar 2026 stood at $5.0 million (changed 0.0% YoY), and the FY2025 full-year result was $5.0 million, changed 0.0% from the prior year.
• Short term Debt was little changed at $5.0 million in Q1 2026, from $5.0 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $8.8 million in Q4 2023 to a low of $3.8 million in Q3 2024.
• A 5-year average of $6.2 million and a median of $7.0 million in 2022 frame the typical range for Short term Debt.
• Across the five-year window, Short term Debt tumbled 46.65% in 2024 and jumped 33.33% in 2025, its largest moves.
• Tracing GDRX's Short term Debt over 5 years: stood at $7.0 million in 2022, then climbed by 25.01% to $8.8 million in 2023, then sank by 43.1% to $5.0 million in 2024, then changed by 0.0% to $5.0 million in 2025, then changed by 0.0% to $5.0 million in 2026.
• Business Quant data shows GDRX's Short term Debt at $5.0 million in Q1 2026, $5.0 million in Q4 2025, and $5.0 million in Q3 2025.